Illumina Inc
(NAS:ILMN)
$
146.17
-1.45 (-0.98%)
Market Cap: 23.18 Bil
Enterprise Value: 25.15 Bil
PE Ratio: 0
PB Ratio: 10.87
GF Score: 80/100 Illumina Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 11, 2021 / 07:00PM GMT
Release Date Price:
$488.7
(-0.71%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
So getting started here in the next panel. Happy to be hosting Francis deSouza from Illumina, President and CEO. Hi, Francis.
Francis A. deSouza
Illumina, Inc. - CEO & Director
John, how are you?
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
Pretty good.
Questions & Answers
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
So I guess maybe just kind of getting started off with Q3 and '21 guidance the company just reported last week. The company has stated that they're seeing activity in both academic and clinical markets above pre-COVID levels. Can you maybe talk on the outlook for these 2 markets? And how has COVID changed the growth dynamics?
Francis A. deSouza
Illumina, Inc. - CEO & Director
Sure, John. Now let me start with the safe
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot